AMC2 MED.B.030 Haematology

• ED Decision 2019/002/R found in: Aircrew (1178/2011) Part-FCL Part-MED Part-CC Part-ARA Part-ORA Part-DTO (Dec 2024)

AMC2 MED.B.030 Haematology ED Decision 2019/002/R (a)     Abnormal haemoglobin Haemoglobin should be tested when clinically indicated. (b)     Anaemia Applicants with anaemia demonstrated by a reduced haemoglobin level or low haematocrit may be assessed as fit once the primary cause has been treated and the haemoglobin or haematocrit has stabilised at a satisfactory level. (c)      Erythrocytosis Applicants with erythrocytosis may be assessed as fit if the condition is stable and no associated pathology is demonstrated. (d)     Haemoglobinopathy Applicants with a haemoglobinopathy may be assessed as fit if minor thalassaemia or other haemoglobinopathy is diagnosed without a history of crises and where full functional capability is demonstrated. (e)     Coagulation and haemorrhagic disorders Applicants with a coagulation or haemorrhagic disorder may be assessed as fit if there is no likelihood of significant bleeding. (f)      Thromboembolic disorders Applicants with a thrombotic disorder may be assessed as fit if there is minimal likelihood of significant clotting episodes. If anticoagulation is used as treatment, refer to [AMC2 MED.B.010(g)](#_DxCrossRefBm894735880). (g)     Disorders of the lymphatic system Applicants with significant enlargement of the lymphatic glands or haematological disease may be assessed as fit if the condition is unlikely to interfere with the safe exercise of the privileges of the applicable licence(s). Applicants may be assessed as fit in cases of acute infectious process which is fully recovered or Hodgkin's lymphoma or other lymphoid malignancy which has been treated and is in full remission. (h)     Leukaemia (1)     Applicants with acute leukaemia may be assessed as fit once in established remission. (2)     Applicants with chronic leukaemia may be assessed as fit after a period of demonstrated stability. (3)     In cases (h)(1) and (h)(2), there should be no history of central nervous system involvement and no continuing side effects from treatment of flight safety importance. Haemoglobin and platelet levels should be satisfactory. Regular follow-up is required. (i)      Splenomegaly Applicants with splenomegaly may be assessed as fit if the enlargement is minimal, stable and no associated pathology is demonstrated, or if the enlargement is minimal and associated with another acceptable condition. AMC2 MED.B.030 Haematology ED Decision 2019/002/R (a) Abnormal haemoglobin Haemoglobin should be tested when clinically indicated. (b) Anaemia Applicants with anaemia demonstrated by a reduced haemoglobin level or low haematocrit may be assessed as fit once the primary cause has been treated and the haemoglobin or haematocrit has stabilised at a satisfactory level. (c) Erythrocytosis Applicants with erythrocytosis may be assessed as fit if the condition is stable and no associated pathology is demonstrated. (d) Haemoglobinopathy Applicants with a haemoglobinopathy may be assessed as fit if minor thalassaemia or other haemoglobinopathy is diagnosed without a history of crises and where full functional capability is demonstrated. (e) Coagulation and haemorrhagic disorders Applicants with a coagulation or haemorrhagic disorder may be assessed as fit if there is no likelihood of significant bleeding. (f) Thromboembolic disorders Applicants with a thrombotic disorder may be assessed as fit if there is minimal likelihood of significant clotting episodes. If anticoagulation is used as treatment, refer to [AMC2 MED.B.010(g)](#_DxCrossRefBm1199963736). (g) Disorders of the lymphatic system Applicants with significant enlargement of the lymphatic glands or haematological disease may be assessed as fit if the condition is unlikely to interfere with the safe exercise of the privileges of the applicable licence(s). Applicants may be assessed as fit in cases of acute infectious process which is fully recovered or Hodgkin's lymphoma or other lymphoid malignancy which has been treated and is in full remission. (h) Leukaemia (1) Applicants with acute leukaemia may be assessed as fit once in established remission. (2) Applicants with chronic leukaemia may be assessed as fit after a period of demonstrated stability. (3) In cases (h)(1) and (h)(2), there should be no history of central nervous system involvement and no continuing side effects from treatment of flight safety importance. Haemoglobin and platelet levels should be satisfactory. Regular follow-up is required. (i) Splenomegaly Applicants with splenomegaly may be assessed as fit if the enlargement is minimal, stable and no associated pathology is demonstrated, or if the enlargement is minimal and associated with another acceptable condition. ##### AMC2 MED.B.030 Haematology *ED Decision 2019/002/R* (a) Abnormal haemoglobin Haemoglobin should be tested when clinically indicated. (b) Anaemia Applicants with anaemia demonstrated by a reduced haemoglobin level or low haematocrit may be assessed as fit once the primary cause has been treated and the haemoglobin or haematocrit has stabilised at a satisfactory level. (c) Erythrocytosis Applicants with erythrocytosis may be assessed as fit if the condition is stable and no associated pathology is demonstrated. (d) Haemoglobinopathy Applicants with a haemoglobinopathy may be assessed as fit if minor thalassaemia or other haemoglobinopathy is diagnosed without a history of crises and where full functional capability is demonstrated. (e) Coagulation and haemorrhagic disorders Applicants with a coagulation or haemorrhagic disorder may be assessed as fit if there is no likelihood of significant bleeding. (f) Thromboembolic disorders Applicants with a thrombotic disorder may be assessed as fit if there is minimal likelihood of significant clotting episodes. If anticoagulation is used as treatment, refer to [AMC2 MED.B.010(g)](#_DxCrossRefBm1743303544). (g) Disorders of the lymphatic system Applicants with significant enlargement of the lymphatic glands or haematological disease may be assessed as fit if the condition is unlikely to interfere with the safe exercise of the privileges of the applicable licence(s). Applicants may be assessed as fit in cases of acute infectious process which is fully recovered or Hodgkin's lymphoma or other lymphoid malignancy which has been treated and is in full remission. (h) Leukaemia (1) Applicants with acute leukaemia may be assessed as fit once in established remission. (2) Applicants with chronic leukaemia may be assessed as fit after a period of demonstrated stability. (3) In cases (h)(1) and (h)(2), there should be no history of central nervous system involvement and no continuing side effects from treatment of flight safety importance. Haemoglobin and platelet levels should be satisfactory. Regular follow-up is required. (i) Splenomegaly Applicants with splenomegaly may be assessed as fit if the enlargement is minimal, stable and no associated pathology is demonstrated, or if the enlargement is minimal and associated with another acceptable condition.